U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 58

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr1:161275939-161275940
GRCh38:
Chr1:161306149-161306150
MPZL202fsRoussy-Lévy syndromeUncertain significance
(Jul 2, 2019)
criteria provided, single submitter
2.
GRCh37:
Chr1:161276553-161276554
GRCh38:
Chr1:161306763-161306764
MPZN131fsRoussy-Lévy syndromeLikely pathogenic
(Mar 26, 2020)
criteria provided, single submitter
3.
GRCh37:
Chr1:161275306
GRCh38:
Chr1:161305516
MPZNeuropathy, congenital hypomyelinating, 2, not provided, Charcot-Marie-Tooth disease dominant intermediate D,
Charcot-Marie-Tooth disease type 1B, Roussy-Lévy syndrome
Conflicting interpretations of pathogenicity
(Aug 24, 2021)
criteria provided, conflicting interpretations
4.
GRCh37:
Chr1:161275297
GRCh38:
Chr1:161305507
MPZNeuropathy, congenital hypomyelinating, 2, Charcot-Marie-Tooth disease dominant intermediate D, Charcot-Marie-Tooth disease type 1B,
Roussy-Lévy syndrome
Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
5.
GRCh37:
Chr1:161274914
GRCh38:
Chr1:161305124
MPZNeuropathy, congenital hypomyelinating, 2, Charcot-Marie-Tooth disease dominant intermediate D, Charcot-Marie-Tooth disease type 1B,
Roussy-Lévy syndrome
Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
6.
GRCh37:
Chr1:161274763
GRCh38:
Chr1:161304973
MPZNeuropathy, congenital hypomyelinating, 2, Charcot-Marie-Tooth disease type 1B, Charcot-Marie-Tooth disease dominant intermediate D,
Roussy-Lévy syndrome
Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
7.
GRCh37:
Chr1:161277098
GRCh38:
Chr1:161307308
MPZI62VNeuropathy, congenital hypomyelinating, 2, Charcot-Marie-Tooth disease dominant intermediate D, Charcot-Marie-Tooth disease type 1B,
Roussy-Lévy syndrome
Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
8.
GRCh37:
Chr1:161275231
GRCh38:
Chr1:161305441
MPZNeuropathy, congenital hypomyelinating, 2, Charcot-Marie-Tooth disease dominant intermediate D, Charcot-Marie-Tooth disease type 1B,
Roussy-Lévy syndrome
Uncertain significance
(Apr 27, 2017)
criteria provided, single submitter
9.
GRCh37:
Chr1:161275144
GRCh38:
Chr1:161305354
MPZNeuropathy, congenital hypomyelinating, 2, Charcot-Marie-Tooth disease dominant intermediate D, Charcot-Marie-Tooth disease type 1B,
Roussy-Lévy syndrome
Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
10.
GRCh37:
Chr1:161275564
GRCh38:
Chr1:161305774
MPZRoussy-Lévy syndrome, Neuropathy, congenital hypomyelinating, 2, Charcot-Marie-Tooth disease dominant intermediate D,
Charcot-Marie-Tooth disease type 1B
Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
11.
GRCh37:
Chr1:161275325
GRCh38:
Chr1:161305535
MPZRoussy-Lévy syndrome, Neuropathy, congenital hypomyelinating, 2, Charcot-Marie-Tooth disease dominant intermediate D,
Charcot-Marie-Tooth disease type 1B
Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
12.
GRCh37:
Chr1:161276502
GRCh38:
Chr1:161306712
MPZE148DRoussy-Lévy syndrome, Neuropathy, congenital hypomyelinating, 2, Charcot-Marie-Tooth disease dominant intermediate D,
Charcot-Marie-Tooth disease type 1B
Uncertain significance
(Apr 27, 2017)
criteria provided, single submitter
13.
GRCh37:
Chr1:161277109
GRCh38:
Chr1:161307319
MPZV58DCharcot-Marie-Tooth disease, type I, Roussy-Lévy syndromeConflicting interpretations of pathogenicity
(Mar 5, 2022)
criteria provided, conflicting interpretations
14.
GRCh37:
Chr17:15168570
GRCh38:
Chr17:15265253
PMP22Guillain-Barre syndrome, familial, Hereditary liability to pressure palsies, Charcot-Marie-Tooth disease, type IA,
Roussy-Lévy syndrome, Dejerine-Sottas disease, Charcot-Marie-Tooth disease type 1E
Uncertain significance
(Dec 14, 2021)
criteria provided, single submitter
15.
GRCh37:
Chr17:15134355
GRCh38:
Chr17:15231038
PMP22H121Rnot providedUncertain significance
(Feb 16, 2018)
criteria provided, single submitter
16.
GRCh37:
Chr17:15142852
GRCh38:
Chr17:15239535
PMP22C85WGuillain-Barre syndrome, familial, Roussy-Lévy syndrome, Hereditary liability to pressure palsies,
Charcot-Marie-Tooth disease type 1E, Charcot-Marie-Tooth disease, type IA, Dejerine-Sottas disease,
not provided, Inborn genetic diseases, Charcot-Marie-Tooth disease, type I
Uncertain significance
(Jun 13, 2022)
criteria provided, multiple submitters, no conflicts
17.
GRCh37:
Chr1:161276518
GRCh38:
Chr1:161306728
MPZT143MNeuropathy, congenital hypomyelinating, 2, Inborn genetic diseases, not provided,
Charcot-Marie-Tooth disease, type I, Charcot-Marie-Tooth disease type 1B, Charcot-Marie-Tooth disease dominant intermediate D,
Roussy-Lévy syndrome
Uncertain significance
(Aug 23, 2023)
criteria provided, multiple submitters, no conflicts
18.
GRCh37:
Chr1:161276549
GRCh38:
Chr1:161306759
MPZP133TCharcot-Marie-Tooth disease type 2I, Charcot-Marie-Tooth disease type 2J, Roussy-Lévy syndrome,
Charcot-Marie-Tooth disease type 1B, Charcot-Marie-Tooth disease dominant intermediate D, Dejerine-Sottas disease,
Charcot-Marie-Tooth disease type 4E, Charcot-Marie-Tooth disease, type I
Pathogenic/Likely pathogenic
(Jul 5, 2022)
criteria provided, multiple submitters, no conflicts
19.
GRCh37:
Chr17:15134239
GRCh38:
Chr17:15230922
PMP22E160KCharcot-Marie-Tooth disease, type I, Charcot-Marie-Tooth disease type 1E, Guillain-Barre syndrome, familial,
Roussy-Lévy syndrome, Dejerine-Sottas disease, Charcot-Marie-Tooth disease, type IA,
Hereditary liability to pressure palsies
Uncertain significance
(Aug 26, 2021)
criteria provided, multiple submitters, no conflicts
20.
GRCh37:
Chr17:15134321
GRCh38:
Chr17:15231004
PMP22Guillain-Barre syndrome, familial, Charcot-Marie-Tooth disease type 1E, Charcot-Marie-Tooth disease, type IA,
Hereditary liability to pressure palsies, Roussy-Lévy syndrome, Dejerine-Sottas disease,
not provided, Inborn genetic diseases, Charcot-Marie-Tooth disease, type I,
not specified
Benign/Likely benign
(Nov 3, 2022)
criteria provided, multiple submitters, no conflicts
21.
GRCh37:
Chr1:161275714
GRCh38:
Chr1:161305924
MPZS233RRoussy-Lévy syndrome, Sensorimotor neuropathy, EMG: neuropathic changes,
Limb muscle weakness, Tremor
Likely pathogenic
(Jan 1, 2016)
criteria provided, single submitter
22.
GRCh37:
Chr17:15134295
GRCh38:
Chr17:15230978
PMP22V141GRoussy-Lévy syndrome, Spasticity, Respiratory distress,
Tongue fasciculations
Uncertain significance
(Jan 1, 2016)
criteria provided, single submitter
23.
GRCh37:
Chr1:161284158
GRCh38:
Chr1:161314368
MPZ, SDHCParagangliomas 3, Gastrointestinal stroma tumor, not provided,
Hereditary cancer-predisposing syndrome, not specified, Charcot-Marie-Tooth disease type 4E,
Hereditary pheochromocytoma-paraganglioma, Roussy-Lévy syndrome, Pheochromocytoma,
Paragangliomas 3, Charcot-Marie-Tooth, IntermediateCharcot-Marie-Tooth disease, type I,
Paragangliomas 3, Gastrointestinal stroma tumor, Carney-Stratakis syndrome,
...see more
Benign
(Aug 15, 2023)
criteria provided, multiple submitters, no conflicts
24.
GRCh37:
Chr17:15162516
GRCh38:
Chr17:15259199
PMP22Guillain-Barre syndrome, familial, Roussy-Lévy syndrome, Dejerine-Sottas disease,
Hereditary liability to pressure palsies, Charcot-Marie-Tooth disease type 1E, Charcot-Marie-Tooth disease, type IA,
not provided, Inborn genetic diseases, Charcot-Marie-Tooth disease,
Hereditary liability to pressure palsies, Charcot-Marie-Tooth disease, type I ...see more
Benign/Likely benign
(Oct 31, 2022)
criteria provided, multiple submitters, no conflicts
25.
GRCh37:
Chr1:161279744
GRCh38:
Chr1:161309954
MPZNeuropathy, congenital hypomyelinating, 2, Charcot-Marie-Tooth disease type 4E, Charcot-Marie-Tooth disease dominant intermediate D,
Charcot-Marie-Tooth disease type 1B, Roussy-Lévy syndrome
Conflicting interpretations of pathogenicity
(Jan 12, 2018)
criteria provided, conflicting interpretations
26.
GRCh37:
Chr1:161277205
GRCh38:
Chr1:161307415
MPZP26LNeuropathy, congenital hypomyelinating, 2, Charcot-Marie-Tooth disease type 4E, Charcot-Marie-Tooth disease dominant intermediate D,
Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease, type I, Charcot-Marie-Tooth disease type 1B,
Roussy-Lévy syndrome
Conflicting interpretations of pathogenicity
(Apr 20, 2022)
criteria provided, conflicting interpretations
27.
GRCh37:
Chr1:161276199
GRCh38:
Chr1:161306409
MPZCharcot-Marie-Tooth disease, type I, not specified, Neuropathy, congenital hypomyelinating, 2,
not provided, Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease type 4E,
Charcot-Marie-Tooth disease type 1B, Charcot-Marie-Tooth disease dominant intermediate D, Roussy-Lévy syndrome
Benign/Likely benign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
28.
GRCh37:
Chr1:161276188
GRCh38:
Chr1:161306398
MPZL172PCharcot-Marie-Tooth, Intermediate, Charcot-Marie-Tooth disease type 4E, Charcot-Marie-Tooth disease, type I,
Roussy-Lévy syndrome
Uncertain significance
(Jun 14, 2016)
criteria provided, single submitter
29.
GRCh37:
Chr1:161275614
GRCh38:
Chr1:161305824
MPZG267SNeuropathy, congenital hypomyelinating, 2, Charcot-Marie-Tooth disease type 4E, Charcot-Marie-Tooth disease dominant intermediate D,
Charcot-Marie-Tooth disease type 1B, Roussy-Lévy syndrome
Conflicting interpretations of pathogenicity
(Jan 13, 2018)
criteria provided, conflicting interpretations
30.
GRCh37:
Chr1:161275471
GRCh38:
Chr1:161305681
MPZRoussy-Lévy syndrome, Charcot-Marie-Tooth disease type 4E, Charcot-Marie-Tooth disease type 1B,
Charcot-Marie-Tooth disease dominant intermediate D, Neuropathy, congenital hypomyelinating, 2, not provided
Conflicting interpretations of pathogenicity
(Oct 1, 2023)
criteria provided, conflicting interpretations
31.
GRCh37:
Chr1:161275415
GRCh38:
Chr1:161305625
MPZNeuropathy, congenital hypomyelinating, 2, Charcot-Marie-Tooth disease type 4E, Charcot-Marie-Tooth disease dominant intermediate D,
Charcot-Marie-Tooth disease type 1B, Roussy-Lévy syndrome
Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
32.
GRCh37:
Chr1:161275098
GRCh38:
Chr1:161305308
MPZNeuropathy, congenital hypomyelinating, 2, not provided, Charcot-Marie-Tooth disease type 4E,
Charcot-Marie-Tooth disease dominant intermediate D, Charcot-Marie-Tooth disease type 1B, Roussy-Lévy syndrome
Benign/Likely benign
(May 13, 2021)
criteria provided, multiple submitters, no conflicts
33.
GRCh37:
Chr1:161275042
GRCh38:
Chr1:161305252
MPZNeuropathy, congenital hypomyelinating, 2, not provided, Charcot-Marie-Tooth disease type 4E,
Charcot-Marie-Tooth disease dominant intermediate D, Charcot-Marie-Tooth disease type 1B, Roussy-Lévy syndrome
Benign/Likely benign
(May 13, 2021)
criteria provided, multiple submitters, no conflicts
34.
GRCh37:
Chr1:161274985
GRCh38:
Chr1:161305195
MPZNeuropathy, congenital hypomyelinating, 2, Charcot-Marie-Tooth disease type 4E, Charcot-Marie-Tooth disease dominant intermediate D,
Roussy-Lévy syndrome, Charcot-Marie-Tooth disease type 1B
Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
35.
GRCh37:
Chr1:161274923
GRCh38:
Chr1:161305133
MPZNeuropathy, congenital hypomyelinating, 2, Charcot-Marie-Tooth disease type 4E, Charcot-Marie-Tooth disease type 1B,
Charcot-Marie-Tooth disease dominant intermediate D, Roussy-Lévy syndrome
Conflicting interpretations of pathogenicity
(Jan 13, 2018)
criteria provided, conflicting interpretations
36.
GRCh37:
Chr1:161274905
GRCh38:
Chr1:161305115
MPZNeuropathy, congenital hypomyelinating, 2, not provided, Charcot-Marie-Tooth disease type 4E,
Charcot-Marie-Tooth disease type 1B, Charcot-Marie-Tooth disease dominant intermediate D, Roussy-Lévy syndrome
Benign
(May 13, 2021)
criteria provided, multiple submitters, no conflicts
37.
GRCh37:
Chr1:161274808
GRCh38:
Chr1:161305018
MPZCharcot-Marie-Tooth, Intermediate, Charcot-Marie-Tooth disease type 4E, Roussy-Lévy syndrome,
Charcot-Marie-Tooth disease, type I
Uncertain significance
(Jun 14, 2016)
criteria provided, single submitter
38.
GRCh37:
Chr1:161274755-161274756
GRCh38:
Chr1:161304965-161304966
MPZCharcot-Marie-Tooth, Intermediate, not provided, Charcot-Marie-Tooth disease type 4E,
Charcot-Marie-Tooth disease, type I, Roussy-Lévy syndrome
Benign
(May 13, 2021)
criteria provided, multiple submitters, no conflicts
39.
GRCh37:
Chr1:161274712
GRCh38:
Chr1:161304922
MPZNeuropathy, congenital hypomyelinating, 2, Charcot-Marie-Tooth disease type 4E, Charcot-Marie-Tooth disease dominant intermediate D,
Roussy-Lévy syndrome, Charcot-Marie-Tooth disease type 1B
Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
40.
GRCh37:
Chr1:161274646
GRCh38:
Chr1:161304856
MPZNeuropathy, congenital hypomyelinating, 2, Charcot-Marie-Tooth disease type 4E, Charcot-Marie-Tooth disease dominant intermediate D,
Roussy-Lévy syndrome, Charcot-Marie-Tooth disease type 1B
Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
41.
GRCh37:
Chr1:161274618
GRCh38:
Chr1:161304828
MPZnot provided, Charcot-Marie-Tooth disease type 4E, Charcot-Marie-Tooth disease type 1B,
Roussy-Lévy syndrome, Neuropathy, congenital hypomyelinating, 2, Charcot-Marie-Tooth disease dominant intermediate D
Conflicting interpretations of pathogenicity
(May 1, 2023)
criteria provided, conflicting interpretations
42.
GRCh37:
Chr1:161274592
GRCh38:
Chr1:161304802
MPZNeuropathy, congenital hypomyelinating, 2, Charcot-Marie-Tooth disease type 4E, Charcot-Marie-Tooth disease dominant intermediate D,
Charcot-Marie-Tooth disease type 1B, Roussy-Lévy syndrome
Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
43.
GRCh37:
Chr1:161275906
GRCh38:
Chr1:161306116
MPZG213RNeuropathy, congenital hypomyelinating, 2, Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease, type I,
Inborn genetic diseases, not provided, not specified,
Charcot-Marie-Tooth disease type 4E, Charcot-Marie-Tooth disease type 1B, Charcot-Marie-Tooth disease dominant intermediate D,
Roussy-Lévy syndrome
Conflicting interpretations of pathogenicity
(Oct 3, 2022)
criteria provided, conflicting interpretations
44.
GRCh37:
Chr1:161277149
GRCh38:
Chr1:161307359
MPZR45WCharcot-Marie-Tooth disease, type I, Inborn genetic diseases, Charcot-Marie-Tooth disease type 2J,
Charcot-Marie-Tooth disease type 2I, Charcot-Marie-Tooth disease type 1B, Charcot-Marie-Tooth disease dominant intermediate D,
Dejerine-Sottas disease, Roussy-Lévy syndrome, Charcot-Marie-Tooth disease type 4E,
not provided
Conflicting interpretations of pathogenicity
(Oct 10, 2022)
criteria provided, conflicting interpretations
45.
GRCh37:
Chr1:161277082
GRCh38:
Chr1:161307292
MPZR67HCharcot-Marie-Tooth disease, Charcot-Marie-Tooth disease, type I, not specified,
Neuropathy, congenital hypomyelinating, 2, Inborn genetic diseases, Roussy-Lévy syndrome,
not provided, Charcot-Marie-Tooth disease type 1B, Charcot-Marie-Tooth disease dominant intermediate D
Conflicting interpretations of pathogenicity
(Oct 19, 2022)
criteria provided, conflicting interpretations
46.
GRCh37:
Chr17:15134283
GRCh38:
Chr17:15230966
PMP22L145fsCharcot-Marie-Tooth disease, type I, Inborn genetic diseases, not provided,
Roussy-Lévy syndrome, Charcot-Marie-Tooth disease, type IA
Pathogenic/Likely pathogenic
(Sep 17, 2023)
criteria provided, multiple submitters, no conflicts
47.
GRCh37:
Chr1:161276252
GRCh38:
Chr1:161306462
MPZP151TCharcot-Marie-Tooth disease, type I, Charcot-Marie-Tooth disease type 4E, Charcot-Marie-Tooth disease type 2I,
Charcot-Marie-Tooth disease type 2J, Charcot-Marie-Tooth disease type 1B, Charcot-Marie-Tooth disease dominant intermediate D,
Roussy-Lévy syndrome, Dejerine-Sottas disease, not provided
Conflicting interpretations of pathogenicity
(Sep 2, 2021)
criteria provided, conflicting interpretations
48.
GRCh37:
Chr17:15142922
GRCh38:
Chr17:15239605
PMP22L62RGuillain-Barre syndrome, familial, Hereditary liability to pressure palsies, Charcot-Marie-Tooth disease type 1E,
Charcot-Marie-Tooth disease, type IA, Roussy-Lévy syndrome, Dejerine-Sottas disease,
Charcot-Marie-Tooth disease, type I, not specified, not provided
Uncertain significance
(Oct 25, 2022)
criteria provided, multiple submitters, no conflicts
49.
GRCh37:
Chr1:161275943
GRCh38:
Chr1:161306153
MPZNeuropathy, congenital hypomyelinating, 2, Charcot-Marie-Tooth disease, type I, Charcot-Marie-Tooth disease type 2J,
Charcot-Marie-Tooth disease type 2I, Charcot-Marie-Tooth disease type 1B, not specified,
Charcot-Marie-Tooth disease type 4E, Charcot-Marie-Tooth disease type 1B, Charcot-Marie-Tooth disease dominant intermediate D,
Roussy-Lévy syndrome
Benign
(Nov 4, 2022)
criteria provided, multiple submitters, no conflicts
50.
GRCh37:
Chr1:161275729
GRCh38:
Chr1:161305939
MPZNeuropathy, congenital hypomyelinating, 2, Charcot-Marie-Tooth disease, type I, Roussy-Lévy syndrome,
not provided, Charcot-Marie-Tooth disease type 4E, Charcot-Marie-Tooth disease type 1B,
Charcot-Marie-Tooth disease dominant intermediate D, Charcot-Marie-Tooth disease, not specified
Benign/Likely benign
(Nov 4, 2022)
criteria provided, multiple submitters, no conflicts
51.
GRCh37:
Chr1:161284226-161284227
GRCh38:
Chr1:161314434-161314435
MPZ, SDHCCharcot-Marie-Tooth, Intermediate, Gastrointestinal stroma tumor, Paragangliomas 3,
Hereditary cancer-predisposing syndrome, Charcot-Marie-Tooth disease, type I, not specified,
not provided, Charcot-Marie-Tooth disease type 4E, Roussy-Lévy syndrome,
Pheochromocytoma
Benign
(Nov 4, 2022)
criteria provided, multiple submitters, no conflicts
52.
GRCh37:
Chr1:161277096
GRCh38:
Chr1:161307306
MPZI62MCharcot-Marie-Tooth disease, type I, Charcot-Marie-Tooth disease type 2I, Roussy-Lévy syndrome
Conflicting interpretations of pathogenicity
(Mar 14, 2022)
criteria provided, conflicting interpretations
53.
GRCh37:
Chr1:161276512
GRCh38:
Chr1:161306722
MPZY145SMPZ-related condition, Charcot-Marie-Tooth disease type 4E, Roussy-Lévy syndrome,
Charcot-Marie-Tooth disease type 2J, Charcot-Marie-Tooth disease type 1B, Charcot-Marie-Tooth disease type 2I,
Dejerine-Sottas disease, Charcot-Marie-Tooth disease dominant intermediate D, Charcot-Marie-Tooth disease, type I,
not provided
Pathogenic
(Mar 29, 2023)
criteria provided, multiple submitters, no conflicts
54.
GRCh37:
Chr1:161276553
GRCh38:
Chr1:161306763
MPZN131KCharcot-Marie-Tooth disease, type I, not providedPathogenic
(Aug 24, 2021)
criteria provided, multiple submitters, no conflicts
55.
GRCh37:
Chr1:161276575
GRCh38:
Chr1:161306785
MPZT124MInborn genetic diseases, Dejerine-Sottas disease, Charcot-Marie-Tooth disease type 1B,
Charcot-Marie-Tooth disease type 2I, Roussy-Lévy syndrome, Charcot-Marie-Tooth disease type 4E,
Charcot-Marie-Tooth disease type 2J, Charcot-Marie-Tooth disease dominant intermediate D, Charcot-Marie-Tooth disease, type I,
not provided, Charcot-Marie-Tooth disease dominant intermediate D ...see more
Pathogenic
(Jul 1, 2022)
criteria provided, multiple submitters, no conflicts
56.
GRCh37:
Chr1:161276204
GRCh38:
Chr1:161306414
MPZG167RCharcot-Marie-Tooth disease dominant intermediate D, Dejerine-Sottas disease, Charcot-Marie-Tooth disease type 2I,
Charcot-Marie-Tooth disease type 2J, Charcot-Marie-Tooth disease type 1B, Charcot-Marie-Tooth disease type 4E,
Roussy-Lévy syndrome, Charcot-Marie-Tooth disease, type I
Pathogenic
(Aug 27, 2021)
criteria provided, multiple submitters, no conflicts
57.
GRCh37:
Chr17:15164009
GRCh38:
Chr17:15260692
PMP22H12QInborn genetic diseases, Charcot-Marie-Tooth disease, type I, Roussy-Lévy syndrome
Pathogenic/Likely pathogenic
(Sep 19, 2022)
criteria provided, multiple submitters, no conflicts
58.
PMP22Roussy-Lévy syndrome, Charcot-Marie-Tooth disease, type IAPathogenic
(Oct 18, 2012)
no assertion criteria provided
Format
Items per page
Sort by
Choose Destination